兩連板的金域醫學(603882.SH):未來新冠相關檢測業務是否繼續保持增長存在不確定性
格隆匯 1 月 23日丨連續2個漲停的金域醫學(603882.SH)發佈股票交易異常波動公吿,2020年1-9月公司實現營業收入58.27億元,同比增長48.65%,歸屬於上市公司股東淨利潤10.55億元,同比增長230.65%,主要原因系受新冠疫情影響,疫情相關檢測需求大幅增加,但隨着疫情防控進展,未來新冠相關檢測業務是否繼續保持增長存在不確定性。
目前,公司股東上海辰德惟敬投資中心(有限合夥)、國開博裕一期(上海)股權投資合夥企業(有限合夥)、國創開元股權投資基金(有限合夥)、天津君睿祺股權投資合夥企業(有限合夥)、北京君聯茂林股權投資合夥企業(有限合夥)均已披露減持計劃,截至目前,上述減持計劃尚未實施完畢。
經公司自查,並書面徵詢控股股東、實際控制人及其一致行動人,截至公吿披露日,確認不存在應披露而未披露的重大事項或重要信息。
敬請廣大投資者審慎投資、注意風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.